Delivery Order SPE2DB22D3501-SPE2DB26FTH48
- Not listed
- The Defense Logistics Agency awarded a $4,002.34 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This is a firm fixed price, competitively awarded contract with a completion date of August 25, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The pharmaceutical product will be delivered to the vendor's primary location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $4,540.44 with firm fixed pricing. This competitively awarded, non-set-aside delivery order is expected to be completed by September 24, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a routine pharmaceutical procurement under the company's larger federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $2,392.50 under a firm fixed-price contract. This is a competitive, non-set-aside award with an ultimate completion date of October 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the...
- The Defense Logistics Agency awarded a $69,558.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers....
- The Defense Logistics Agency awarded a $4,540.44 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $12,987.73 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader federal supply agreements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $3,267.57 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on August 14, 2025, with a ceiling value of $1,041.42 and an ultimate completion date of August 15, 2025. This competitive, firm fixed-price delivery order represents pharmaceutical supply to support military and federal healthcare requirements. The award is classified as a child contract, indicating it derives from a larger contract vehicle. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with a ceiling value of $1,135.11. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, represents a small-value transaction within the pharmaceutical supply chain. The award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,061.39 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, awarded on October 27, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH48Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This $4,162.07 firm fixed-price delivery order is scheduled for completion by October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under an existing contract vehicle, reflecting the contractor's established relationship with DLA for pharmaceutical supply. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued as a child order under the company's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/29/25 |